• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • 首都科技期刊卓越行动计划
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
韩香妃,侯天宇,赵亚娜,等. 柚皮素及柚皮苷抑制牛血清蛋白糖化机理J. 食品工业科技,2026,47(16):1−10. doi: 10.13386/j.issn1002-0306.2025070222.
引用本文: 韩香妃,侯天宇,赵亚娜,等. 柚皮素及柚皮苷抑制牛血清蛋白糖化机理J. 食品工业科技,2026,47(16):1−10. doi: 10.13386/j.issn1002-0306.2025070222.
HAN Xiangfei, HOU Tianyu, ZHAO Yana, et al. Mechanisms of Naringenin and Naringin in Inhibiting the Glycation of Bovine Serum AlbuminJ. Science and Technology of Food Industry, 2026, 47(16): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025070222.
Citation: HAN Xiangfei, HOU Tianyu, ZHAO Yana, et al. Mechanisms of Naringenin and Naringin in Inhibiting the Glycation of Bovine Serum AlbuminJ. Science and Technology of Food Industry, 2026, 47(16): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025070222.

柚皮素及柚皮苷抑制牛血清蛋白糖化机理

Mechanisms of Naringenin and Naringin in Inhibiting the Glycation of Bovine Serum Albumin

  • 摘要: 为探究柚皮素及柚皮苷两种黄酮类化合物对晚期糖基化终末产物(Advanced glycation end products,AGEs)的抑制机制,本文通过构建牛血清蛋白(Bovine serum albumin,BSA)-果糖和BSA-甲基乙二醛(Methylglyoxal,MGO)模型体系,测定柚皮素和柚皮苷对反应中不同阶段糖基化产物的抑制作用及对蛋白质结构的保护作用,同时检测了二者与MGO所产生加合物的结构,进而探讨两者抗糖化的能力。结果表明,柚皮素和柚皮苷对AGEs的抑制率随浓度的增大而增加,当柚皮素和柚皮苷浓度为2 mg/mL时,其对BSA-果糖和BSA-MGO体系中AGEs的抑制率均超过80%,显著(P<0.05)优于氨基胍;在蛋白质结构保护方面,二者可以保护蛋白荧光团微环境,使荧光回收率达40%以上;增加游离巯基含量,对犬尿氨酸的抑制率均达到95%以上,有效抑制蛋白氧化产物的生成;高效液相色谱-质谱联用(High performance liquid chromatography-Mass Spectrometry,HPLC-MS)分析显示,柚皮素和柚皮苷在与MGO反应后均生成单加合物和双加合物。综上所述,柚皮素以及柚皮苷具有良好的抗糖化效果,并且它们通过抗氧化作用、捕获中间产物和螯合金属离子来达到抑制AGEs的效果。这些发现表明柚皮素和柚皮苷可以作为一种安全、有效的AGEs抑制剂,在食品、医药等领域具有一定的应用前景。

     

    Abstract: In this study, we established bovine serum albumin (BSA)-fructose and a BSA-methylglyoxal (MGO) model system to explore the inhibitory mechanisms of two flavonoids, naringenin and naringin, against advanced glycation end products (AGEs). The inhibitory effects of naringenin and naringin on the glycation products at different stages of the reaction and their protective effects on the protein structures were measured. Notably, the structures of the adducts formed by them and MGO were elucidated to further investigate their anti-glycation abilities. The results showed that the inhibitory rates of naringenin and naringin against AGEs increased with increasing concentration. When the naringenin and naringin concentration was 2 mg/mL, their inhibitory rates against AGEs in both the BSA-fructose and BSA-MGO systems were >80%, which was significantly higher (P<0.05) than that of aminoguanidine. In terms of protein structure protection, they protected the microenvironment of protein fluorophores, with a fluorescence recovery rate of >40%. In addition, they increased the content of free sulfhydryl groups as well as the inhibitory rate against kynurenine, both of which reaching >95%. These increases effectively inhibited the formation of protein oxidation products. High-performance liquid chromatography-mass spectrometry (HPLC-MS) showed that both naringenin and naringin formed mono-adducts and bis-adducts after reacting with methylglyoxal (MGO). Collectively, our findings revealed that naringenin and naringin had good anti-glycation effects and inhibit AGEs through antioxidant action, thereby capturing intermediate products and chelating metal ions. These results indicate that naringenin and naringin can serve as safe and effective AGEs inhibitors with potential applications in food and medicine.

     

/

返回文章
返回